Clinical Characteristics and Interpretive Challenges of CSF Varicella-Zoster Virus Detection by Metagenomic Next-Generation Sequencing: A Retrospective Case Series.
Wei Yan Y, Wang Xuyi X, Yu Weitong W, Zhao Chenxi C et al.
Varicella-zoster virus (VZV) may cause heterogeneous central nervous system (CNS) manifestations, often without a typical herpes zoster rash. Metagenomic next-generation sequencing (mNGS) enables broad pathogen detection in cerebrospinal fluid (CSF), but VZV reads may be difficult to interpret when additional microorganisms are detected or confirmatory testing is incomplete. This study described the clinical characteristics and interpretive challenges of patients with suspected CNS infection in whom VZV was detected in CSF by mNGS. This retrospective descriptive case series included patients evaluated at The Second Qilu Hospital of Shandong University from January 2019 to December 2024. Among 278 patients with suspected CNS infection who underwent CSF mNGS, 23 met the prespecified operational inclusion criteria. Clinical, CSF, neuroimaging, microbiological, treatment, and short-term outcome data were reviewed. Detected microorganisms were interpreted through integrated clinical assessment rather than sequencing findings alone. No comparison group was included. VZV reads meeting the inclusion criteria were detected in 23 of 278 patients (8.3%). The median age was 44 years, and 15 patients (65.2%) were male. Clinical syndromes spanned encephalitis, meningitis, meningoencephalitis, encephalomyelitis, and myelitis. A herpes zoster-associated rash was present in 10 patients (43.5%). All patients had CSF leukocytosis with lymphocytic predominance, and 21 (91.3%) had elevated CSF protein. VZV-specific polymerase chain reaction was not performed. Qualitative CSF anti-VZV IgM and IgG testing was performed in six patients, of whom two had positive IgM results. Additional microorganisms were co-detected in six patients, including Epstein-Barr virus, low-abundance herpes simplex virus type 1, and Listeria monocytogenes. The median Karnofsky Performance Status score at discharge was 90 (interquartile range, 90-100), with three patients (13.0%) scoring below 90. VZV detection by CSF mNGS occurred across heterogeneous neurological presentations, sometimes alongside additional microorganisms. VZV reads alone cannot establish pathogen causality, and their clinical significance requires integrated assessment of the neurological syndrome, CSF findings, neuroimaging, conventional microbiological investigations, immune status, co-detected microorganisms, and clinical course. The findings are descriptive and do not establish the diagnostic accuracy of mNGS.